RT Journal Article
SR Electronic
T1 SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.29.20116426
DO 10.1101/2020.05.29.20116426
A1 Appa, Ayesha
A1 Chamie, Gabriel
A1 Sawyer, Aenor
A1 Baltzell, Kimberly
A1 Dippell, Kathryn
A1 Ribeiro, Salu
A1 Duarte, Elias
A1 Vinden, Joanna
A1 ,
A1 Kramer-Feldman, Jonathan
A1 Rahdar, Shahryar
A1 MacIntosh, Doug
A1 Nicholson, Katherine
A1 Im, Jonathan
A1 Havlir, Diane
A1 Greenhouse, Bryan
YR 2020
UL http://medrxiv.org/content/early/2020/05/30/2020.05.29.20116426.abstract
AB High-volume, community-wide ascertainment of SARS-CoV-2 prevalence by PCR and antibody testing was successfully performed using a community-led, drive-through model with strong operational support, well-trained testing units, and an effective technical platformCompeting Interest StatementThe authors have declared no competing interest.Funding StatementFinancial Support This work was primarily supported by the Bolinas Community Land Trust. Additional sources of support included funding from the Chan Zuckerberg Biohub Investigator program (BG) and the National Institutes of Health grant 5T32AI007641-17 (AA). Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB Approval The aforementioned procedures were submitted to the University of California San Francisco institutional review board for approval, and the study was deemed public health surveillance not requiring IRB oversight [IRB number 20-30636]. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis manuscript does not contain patient-level data.